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The radiation inactivation method has been used to determine the molecular mass of membrane-bound 
acid &glucosidase (EK 3.2.1.21) in situ, in normal human spleen and in that of two patients with type I 
Gaucher disease: the molecular mass in Gaucher spleen is about double (125 000 f 8900) of that found in 
the normal spleen (67 000 f 7700) which is compatible with the existence of subunit coupling in the muted 
acid&glucosidase. From the results, we conclude that subunit interaction isaltered in mutant acid&gluco- 
sidase and that this may be due to a direct effect of the mutation. 
Radiation inactivation method Membrane-bound acid @-glucosidase Gaucher disease 
1. INTRODUCTION 
Gaucher disease is the most common inherited 
disorder that primarily affects Ashkenazi Jewish 
people [l]. The genetic defect in this disease con- 
sists in a deficiency of a membrane-bound lysoso- 
ma1 acid ,&glucosidase which catalyzes glucocere- 
broside hydrolysis. This enzyme has been purified 
and characterized from human placenta and spleen 
after solubilization by detergent [2-61. It appears 
to be a tetramer composed of identical subunits of 
molecular mass between 57000 and 67 000 by 
SDS-polyacrylamide gel electrophoresis [2,5-71. 
Similar subunit &values were obtained for puri- 
fied acid &glucosidase of normal (66000) and 
Gaucher spleen (57 000) [5]. However, the physical 
state of the enzyme in the membrane, and the ef- 
fect of the Gaucher mutation on subunit inter- 
action are unknown. 
bound enzymes without prior solubilization or 
purification [8,9]. We have used this method to de- 
termine the M, of membrane-bound acid,&glucosi- 
dase, and to probe subunit interaction in normal 
human spleen and in that of patients affected with 
type I Gaucher disease. 
2. MATERIALS AND METHODS 
Homogenates from two normal spleens and two 
type I Gaucher patients (0. I5 g tissue/ml) were pre- 
pared in deionized water using an Ultraturax homo- 
genizer (at 4°C) and centrifuged at 220000 x g for 
1 h. The membrane fractions were resuspended in 
the initial volume of water and used for the irradia- 
tion experiments. In some experiments, 0.25% 
(v/v) Triton X 100 was added to the membrane 
fractions to solubilize the acid ,&lucosidase acti- 
vity [lo]. 
The radiation inactivation method allows us to 
determine in situ molecular mass of membrane- 
~bbreviations~ NBD, ~2-[N-methyI-N-(7-nitrobenz-2- 
oxa-1,3-diazol-4-ylfl aminododecanoic a id; MU, 4- 
methylumbelliferyl 
Aliquots (1 ml) of the membrane preparations 
were lyophilized in 1 .S ml Eppendorf microfuge 
tubes. The tubes were flushed with nitrogen and 
irradiated at room temperature (26 + 2°C) in a 
%o irradiator (Gammacell model 220, Atomic 
Energy of Canada, Ottawa). The irradiator was 
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calibrated with enzymes of known radiation sensi- 
tivities as in [I 11. The tubes were placed in a special 
support designed to provide isodose exposure at 
about 0.1 Mrad/h [12]. Three tubes were irradiated 
for each dose and control non-irradiated tubes 
were run concurrently. The logarithm of remaining 
enzyme activity was plotted vs radiation dose and 
a straight line was fitted through the points using 
the least-squares method. The molecular mass was 
determined using a modification of the equation in 
]91: 
M, = (1.48 X I@) ,UD, 
where ,UD is the enzyme activity decay coefficient 
corresponding to the slope of the least-squares 
line. 
Acid fl-glucosidase activity was assayed with the 
MU-&glucoside substrate in the presence of Triton 
X-100 and taurocholate [10,13,14] to inhibit non- 
specific&glucosidase, with the NBD-glucosylcera- 
mide substrate as in [ 151 and with the [ ‘HI-glucosyl- 
ceramide substrate as in [lo]. N-Acetylhexosamini- 
dase was assayed as in [16] and sphingomyelinase 
as in [17]. 
3. RESULTS 
The radiation inactivation of membrane-bound 
acid&glucosidase, assayed with both MU-P-gluco- 
side and NBD-glucosylceramide as substrates is 
shown in fig.1 for normal and Gaucher spleens. 
Corresponding M, values for acid ,&glucosidase 
and control enzymes, N-acetylhexosaminidase and 
sphingomyelinase, are given in table 1. The ma- 
jority of residual acid fl-glucosidase activity in the 
Gaucher spleen (about 17% of normal activity) 
corresponds to a molecule about 2-times larger in 
size than that in the normal spleen. It is also pos- 
sible that the Gaucher spleen contains one or more 
higher M, aggregates of the enzyme since, as shown 
in fig. 1, a rapid loss of acid fi-glucosidase activity 
was observed at low radiation doses. However, the 
molecular mass of these acid /?-glucosidase compo- 
nents cannot be determined with precision under 
our experimental conditions since only a relatively 
small amount is present in the Gaucher spleen. Be- 
cause of these difficulties, we used the slope of the 
least-squares lines @D) depicted in fig.1 (the en- 
zyme activity decay as a function of radiation 
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Fig.1. Radiation inactivation of acid ,&glucosidase in 
normal (0) and Gaucher (0) spleens as determined with 
NBD-glucosylceramide (A) and 4-MU-&glucoside (B) 
as substrates. Initial activities of acid fl-glucosidase were 
as follows: with the NBD-glucosylceramide substrate, 
420nmol. h-‘.g tissue-’ for normal spleen, and 
59 nmol-’ . h-’ .g tissue-’ -’ for the Gaucher spleen; 
with the 4-MU-fi-glucoside substrate, 1300 nmol. h-r. g 
tissue-’ for normal spleen and 250nmollr . h-‘.g tis- 
sue-’ for the Gaucher spleen. Typical experiments are 
shown. 
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Table 1 
M, of membrane-bound acid ,&glucosidase and control enzymes by radiation inactivation 
Enzyme Normal spleen Gaucher spleen 
pD (Mrad-‘) M, pD (Mrad-‘) M, 
Acid ,&glucosidase 
MU-fl-glucoside MBb 0.052 * O.OOY 78000+ 6800 0.106 + 0.015 160000~ 23000 
Sb 0.048, 0.052 72000 f 77000 0.078, 0.081 115000, 120000 
NBD-glucosylceramide MB 0.045 f 0.005 67000+ 7700 0.084 + 0.006 125000* 8900 
S 0.037, 0.043 64000, 55000 0.078, 0.104 116000, 154000 
N-Acetylhexosaminidase 0.068 f 0.002 lOlOOO+ 3600 0.067 + 0.007 lOOOOO* 9900 
Sphingomyelinase 0.057 f 0.008 86000 f 12000 0.059 + 0.009 90000+ 14000 
a Mean f SD of 4 different experiments from 2 normal and 2 type I Gaucher spleens 
bMB, membrane-bound; S, solubilized enzyme in presence of 0.25% (v/v) Triton X-100 
dose) to calculate molecular mass according to a 
modified equation in [9] (see section 2). 
The radioactive [3H]glucosylceramide substrate 
was also used to assay the acid ,&glucosidase acti- 
vity in irradiated normal spleen preparations. We 
report a Mr similar to that found with the NBD- 
glucosylceramide (-60000). However, this sub- 
strate was not sensitive enough to detect the low 
acid fi-glucosidase activities obtained after radia- 
tion inactivation of the Gaucher spleen enzyme 
(not shown). 
Consistently higher M,-values were found for 
acid &glucosidase assayed with the MU-fl-glucosi- 
dase than with the NBD-glucosylceramide sub- 
strate (table 1); although the difference was not 
statistically significant (Student’s t-test, p > 0.05, 
N= 4). It must be pointed out that the latter sub- 
strate is more specific to acid&glucosidase whereas 
the former is also hydrolyzed by a non-specific 
membrane-bound spleen P-glucosidase which has a 
A4, of - 100 000 by radiation inactivation (unpub- 
lished data). Although this non-specific &glucosi- 
dase is largely inhibited by the addition of tauro- 
cholate and Triton X-100 to the assay medium it 
could still interfere with the assay of acid p- 
glucosidase using the MU-P-glucoside substrate 
[10,13,14]. 
brane by 0.25% (v/v) Triton X-100, prior to 
irradiation, did not alter the sizes of the molecules 
in both normal and Gaucher spleens, respectively 
(table 1). 
The control enzymes N-acetylhexosaminidase 
(soluble) and sphingomyelinase (membrane-bound) 
had about the same A4, in the normal and Gaucher 
spleens (table 1). The h4, of spleen N-acetylhexo- 
saminidase corresponded to that of the oligometric 
form of the enzyme as reported by other authors in 
human tissues (100000, [18]). With the spleen 
sphingomyelinase, we report a MI-value slightly 
higher than that of the subunit of the purified 
human brain (70000, [19]) and placentral (70 500, 
[20]) enzymes. 
4. DISCUSSION 
The subunit A4, of purified acid&glucosidase, as 
determined by SDS-polyacrylamide gel electro- 
phoresis, was reported to be around 6OOCKl in the 
human placenta [2], 66000 in the normal human 
spleen and 57 000 in the Gaucher spleen [5]. In nor- 
mal cultured skin fibroblasts 3 different polypep- 
tides with M,-values 63 000, 61000 and 56 000 re- 
acting with an antibody prepared against purified 
placental acid ,&glucosidase were reported [7]. 
They reported that in type I Gaucher fibroblasts, 
only the 56000 M, form was present. With the 
radiation inactivation method, we report for the 
normal spleen acid ,&glucosidase a Mr corres- 
ponding about, considering an experimental error 
of lo-15% [8], to that of the enzyme subunit as 
determined by other authors using SDS-polyacryl- 
amide gel electrophoresis [2,5-71. Since the size of 
95 
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the subunit of residual acid P-glucosidase in spleen 
[SJ and cultured skin fibroblasts [7] of type I 
Gaucher patients is only slightly different from 
that of the normal enzyme, the results of the radia- 
tion inactivation experiment suggest hat two sub- 
units are coupled in the mutant enzyme. However, 
the nature of the subunits involved, with respect o 
the different types identified in cultured skin fibro- 
blasts in [7], cannot be specified due to the experi- 
mental error in M, determination. 
Coupled subunits have also been found for 
spleen N-acetylhexosaminidase (the Mr corres- 
ponds to that of the oligomeric form of the enzyme 
1181) but not for sphingomyelinase (table l), has 
been suggested [8] that the radiation inactivation 
method is sensitive to the size of the functional unit 
of a molecule (the minimal structural assembly 
necessary for the expression of a given biological 
function) or reflects the degree of coupling be- 
tween subunits which would be responsible for 
energy transfer after a direct hit. A distinct possi- 
bility is that subunit interaction may be required 
for the expression of biological activity [S]. The 
destruction of one subunit in an oligomer may be 
responsible for the loss of activity in all associated 
subunits. This interaction may be necessary to 
maintain the conformation of the active site or of 
another enzyme binding site implicated in the acti- 
vation or stabilization of the enzyme. Although we 
cannot choose between these possibilities at the 
present time, the results of the radiation inactiva- 
tion of normal and Gaucher spleen acid P-glucosi- 
dase clearly involve subunit interaction in the 
mutant enzyme. 
The larger A4 obtained for the Gaucher acid 
@-glucosidase does not seem to be due to a genera- 
lized membrane defect or the accumulation of 
lipids in the Gaucher spleen. The control enzymes, 
N-acetylhexosaminidase and sphingomyelinase, 
are not altered in the Gaucher spleen (table 1). in 
addition, Triton X 100~solubilized acid ,&glucosi- 
dase had a similar MI-value to the found in the in- 
tact membranes from normal and Gaucher spleens, 
respectively (table 1). 
In conclusion, we report that the acid &glucosi- 
dase in Gaucher spleen has a different structure as 
determined by the radiation inactivation method. 
It appears that subunit interaction (or coupling) is 
present in the Gaucher acid @glucosidase so that 
energy transfer occurs when one of the subunits is 
96 
hit by an ionizing radiation or that subunit inter- 
action is necessary for the expression of residual 
enzyme activity. The radiation inactivation reveals 
a detail of the mutant enzyme structure, not de- 
tected by other methods, which could represent a 
direct effect of the type I Gaucher mutation on the 
enzyme. 
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